All listings for this product
About this product
- DescriptionThe Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the volumius encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.
- Author BiographyDr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
- PublisherElsevier Science & Technology
- Date of Publication01/07/2008
- SubjectClinical Medicine: Professional
- Series TitleSide Effects of Drugs Annual
- Series Part/Volume Number30
- Place of PublicationOxford
- Country of PublicationUnited Kingdom
- ImprintElsevier Science Ltd
- Content Noteblack & white illustrations
- Weight1410 g
- Width165 mm
- Height240 mm
- Spine38 mm
- Edited byJeffrey K. Aronson
Best-selling in Non-Fiction Books
Save on Non-Fiction Books
- AU $35.04Trending at AU $36.68
- AU $27.64Trending at AU $34.94
- AU $28.63Trending at AU $30.35
- AU $32.21Trending at AU $40.58
- AU $18.13Trending at AU $24.26
- AU $39.30Trending at AU $40.16
- AU $34.17Trending at AU $35.20
This item doesn't belong on this page.
Thanks, we'll look into this.